Back

Oral anticoagulation after catheter ablation: does continuation or discontinuation affect major cardiovascular outcomes? a systematic review and meta-analysis of 143,855 patients

28 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation ablation: insights from systematic reviews and meta-analyses Oral Anticoagulation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Manuel Alonso Ramirez Benavides

Lima (Peru)

5 More presentations in this session

Presentation thumbnail
Peri-ablation semaglutide exposure and atrial fibrillation recurrence: a meta-analysis of time-to-event outcomes
Doctor A. Abdulrazzaq (Brooklyn, US)
Abstract Slides Video
Presentation thumbnail
Impact of Glucagon-like peptide-1 receptor agonists on atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis
Doctor E. Rodriguez (Chicago, US)
Abstract Slides Video
Presentation thumbnail
Glp-1 receptor agonists as adjunctive therapy to catheter ablation in atrial fibrillation: a systematic review and meta-analysis
Doctor S. Deaconu (Bucharest, RO)
Abstract Slides Video
Presentation thumbnail
Contemporary pulsed field ablation systems for atrial fibrillation: a systematic review and network meta-analysis
Doctor A. Leow (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Impact of continuous positive airway pressure therapy for obstructive sleep apnea on atrial fibrillation recurrence following catheter ablation: a comprehensive systematic review and meta-analysis
Doctor R. Khan (IN) Doctor H. Ramteke (Chimur, IN)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation ablation: insights from systematic reviews and meta-analyses

The Event

Event poster

ESC Congress 2026

28 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Safety of discontinuing anticoagulation after atrial fibrillation ablation
30 August 2025
thumbnail
Congress Presentation
Catheter ablation as first versus second-line therapy for atrial fibrillation: a frequentist and bayesian meta-analysis with reconstructed time-to-event and trial sequential analysis
14 April 2026
thumbnail
Congress Presentation
Discontinuation of oral anticoagulation after successful atrial fibrillation treatment with radiofrequency and pulsed-field ablation
13 April 2026
thumbnail
Congress Presentation
Strive for sinus rhythm: only sinus rhythm will do
11 May 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources